Assessing the role of ADAM10 in Trastuzumab treatment and resistance
<p>Overexpression of the HER2 receptor occurs in about 15-20% of all breast cancers and is correlated with poor prognosis. Trastuzumab (Herceptin®), a monoclonal antibody targeting HER2, was shown to prolong survival of these patients. However, primary or acquired resistance remains a drawback...
Príomhchruthaitheoir: | Feldinger, K |
---|---|
Rannpháirtithe: | Kong, A |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2012
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Functional organisation of the Hrd1 ubiquitin ligase complex and its role in ERAD
de réir: Schulz, J
Foilsithe / Cruthaithe: (2013) -
The role and regulation of Asterless in the centrosome cycle
de réir: Novak, ZA
Foilsithe / Cruthaithe: (2014) -
Characterisation of AEBP2: a polycomb repressive complex 2 component
de réir: Grijzenhout, A
Foilsithe / Cruthaithe: (2013) -
Cell stress response and hypoxia in breast cancer
de réir: Milani, M, et al.
Foilsithe / Cruthaithe: (2011) -
Nitric oxide: a chemical effector of pathogenesis in magnaporthe oryzae
de réir: Johnson, J
Foilsithe / Cruthaithe: (2011)